We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+19.99%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.24B
AUM Growth
+$190M
Cap. Flow
+$44.3M
Cap. Flow %
3.57%
Top 10 Hldgs %
53.49%
Holding
86
New
11
Increased
17
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
XENE icon
Xenon Pharmaceuticals
XENE
+$36.9M
2
ATEC icon
Alphatec Holdings
ATEC
+$35.2M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$22.6M
4
NEO icon
NeoGenomics
NEO
+$14.7M
5
INSP icon
Inspire Medical Systems
INSP
+$14.3M

Top Sells

Rank Stock Value
1
OFIX icon
Orthofix Medical
OFIX
+$23.8M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$22.4M
3
GPCR icon
Structure Therapeutics
GPCR
+$18.9M
4
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$17M
5
HCAT icon
Health Catalyst
HCAT
+$15.7M

Sector Composition

Rank Sector Weight
1 Healthcare 95.85%
2 Communication Services 3.34%
3 Industrials 0.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$90.9M 7.31%
287,037
-16,100
-5% -$3.13M
ATEC icon
2
Alphatec Holdings
ATEC
$1.46B
$90.3M 7.27%
5,976,851
+2,943,310
+97% +$35.2M
XENE icon
3
Xenon Pharmaceuticals
XENE
$6.06B
$75.8M 6.1%
1,645,490
+1,043,420
+173% +$36.9M
CRNX icon
4
Crinetics Pharmaceuticals
CRNX
$8.84B
$70.7M 5.69%
1,987,772
+404,443
+26% +$12.4M
PLRX icon
5
Pliant Therapeutics
PLRX
$64.4M
$65M 5.23%
3,591,776
+658,516
+22% +$10M
NEO icon
6
NeoGenomics
NEO
$1.96B
$63.5M 5.11%
3,926,756
+897,843
+30% +$14.7M
TMDX icon
7
Transmedics
TMDX
$2.64B
$59.5M 4.79%
754,317
+136,217
+22% +$8.22M
SIBN icon
8
SI-BONE Inc
SIBN
$788M
$53.5M 4.3%
2,547,392
+23,299
+0.9% +$431K
ATRC icon
9
AtriCure
ATRC
$1.92B
$48.2M 3.87%
1,349,443
-139,964
-9% -$5.21M
FNA
10
DELISTED
Paragon 28, Inc.
FNA
$47.5M 3.82%
3,817,794
+1,079,916
+39% +$11.4M
MODN
11
DELISTED
MODEL N, INC.
MODN
$41.5M 3.34%
1,540,708
-345,510
-18% -$8.32M
TCMD icon
12
Tactile Systems Technology
TCMD
$635M
$40.9M 3.29%
2,859,954
+788,535
+38% +$9.9M
PRTA icon
13
Prothena Corp
PRTA
$425M
$39.6M 3.18%
1,088,801
-405,238
-27% -$15.6M
RARE icon
14
Ultragenyx Pharmaceutical
RARE
$2.45B
$35.6M 2.86%
744,665
-380,367
-34% -$14.7M
PHLT
15
DELISTED
Performant Healthcare Inc
PHLT
$30.2M 2.43%
9,670,110
+291,814
+3% +$765K
BCYC
16
Bicycle Therapeutics
BCYC
$269M
$28M 2.26%
1,550,471
-520,382
-25% -$8.61M
ANAB icon
17
AnaptysBio
ANAB
$1.58B
$26.5M 2.13%
1,237,178
+446,372
+56% +$7.7M
OPRX icon
18
OptimizeRx
OPRX
$114M
$24.7M 1.99%
1,727,298
-758,749
-31% -$7.28M
SWAV
19
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$22.8M 1.83%
+119,623
New +$22.6M
INSM icon
20
Insmed
INSM
$21.4B
$20M 1.61%
646,057
+2,469
+0.4% +$64K
STVN icon
21
Stevanato
STVN
$5.42B
$19.9M 1.6%
729,961
+145,206
+25% +$4.18M
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
$19.8M 1.6%
318,668
-2,505
-0.8% -$140K
INSP icon
23
Inspire Medical Systems
INSP
$1.45B
$18M 1.45%
+88,523
New +$14.3M
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$11.6B
$17.9M 1.44%
185,579
+123,823
+201% +$11M
TELA icon
25
TELA Bio
TELA
$32.7M
$16.9M 1.36%
2,554,641
+74,377
+3% +$430K
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, First Light Asset Management held 86 positions worth $1.24B, up 18% from $1.05B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

First Light Asset Management deployed $44.3M of net new capital in Q4 2023, opening 11 new positions and adding to 17 existing holdings. Its largest new stake was Shockwave Medical, Inc. Common Stock: 119,623 shares worth $22.8M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $22.4M trimmed.

  • First Light Asset Management's largest Q4 2023 buy was Shockwave Medical, Inc. Common Stock: 119,623 shares worth $22.8M.
  • First Light Asset Management added most to Xenon Pharmaceuticals in Q4 2023, an estimated $36.9M increase.
  • First Light Asset Management's biggest Q4 2023 reduction was Tandem Diabetes Care, cutting an estimated $22.4M.
  • First Light Asset Management fully exited Orthofix Medical in Q4 2023, selling an estimated $23.8M.
  • First Light Asset Management's ten largest holdings make up 53% of its $1.24B portfolio in Q4 2023.
  • First Light Asset Management opened 11 new positions and closed 11 in Q4 2023.
  • First Light Asset Management's portfolio value rose 18% quarter-over-quarter to $1.24B.

Based on First Light Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.